[{"address1": "245 Main Street", "address2": "Second Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 500 8080", "website": "https://immuneering.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 66, "companyOfficers": [{"maxAge": 1, "name": "Dr. Benjamin J. Zeskind M.B.A., Ph.D.", "age": 42, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 935085, "exercisedValue": 0, "unexercisedValue": 1146738}, {"maxAge": 1, "name": "Mr. Robert J. Carpenter M.B.A., M.S.", "age": 78, "title": "Co-Founder & Chair Emeritus", "yearBorn": 1946, "fiscalYear": 2023, "totalPay": 75357, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brett M. Hall Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 905415, "exercisedValue": 0, "unexercisedValue": 1402731}, {"maxAge": 1, "name": "Mr. Harold E. Brakewood", "age": 58, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 579769, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mallory  Morales CPA", "age": 40, "title": "Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Paula  George CPA", "title": "Director of Accounting & Operations and Assistant Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael D. Bookman J.D.", "age": 37, "title": "Chief Legal Officer & Secretary", "yearBorn": 1987, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leah R. Neufeld", "age": 51, "title": "Chief People Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  King Ph.D.", "title": "Head of Discovery & VP", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Praveen  Nair Ph.D.", "title": "Head of Translational Pharmacology & VP", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.51, "open": 1.53, "dayLow": 1.51, "dayHigh": 1.5801, "regularMarketPreviousClose": 1.51, "regularMarketOpen": 1.53, "regularMarketDayLow": 1.51, "regularMarketDayHigh": 1.5801, "payoutRatio": 0.0, "beta": -0.327, "forwardPE": -0.9268293, "volume": 179336, "regularMarketVolume": 179336, "averageVolume": 2028366, "averageVolume10days": 239580, "averageDailyVolume10Day": 239580, "bid": 1.5, "ask": 1.59, "bidSize": 2, "askSize": 2, "marketCap": 47196608, "fiftyTwoWeekLow": 1.0, "fiftyTwoWeekHigh": 6.65, "fiftyDayAverage": 1.9372, "twoHundredDayAverage": 1.746925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 779974, "profitMargins": 0.0, "floatShares": 22397620, "sharesOutstanding": 31050400, "sharesShort": 1735510, "sharesShortPriorMonth": 3027573, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0559, "heldPercentInsiders": 0.27813998, "heldPercentInstitutions": 0.13994999, "shortRatio": 3.86, "shortPercentOfFloat": 0.074, "impliedSharesOutstanding": 31050400, "bookValue": 1.859, "priceToBook": 0.8176439, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -58068616, "trailingEps": -1.97, "forwardEps": -1.64, "enterpriseToEbitda": -0.013, "52WeekChange": -0.7455771, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 1.52, "targetHighPrice": 25.0, "targetLowPrice": 1.5, "targetMeanPrice": 11.91667, "targetMedianPrice": 12.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 50657732, "totalCashPerShare": 1.631, "ebitda": -61426520, "totalDebt": 4241026, "quickRatio": 7.321, "currentRatio": 7.986, "debtToEquity": 7.347, "returnOnAssets": -0.42354, "returnOnEquity": -0.71806, "freeCashflow": -32061940, "operatingCashflow": -52264260, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Immuneering Corporation", "longName": "Immuneering Corporation", "regularMarketChangePercent": 0.66225106, "regularMarketPrice": 1.52, "corporateActions": [], "postMarketTime": 1741390655, "regularMarketTime": 1741381201, "exchange": "NGM", "messageBoardId": "finmb_308350677", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "fiftyDayAverageChange": -0.41719997, "fiftyDayAverageChangePercent": -0.21536237, "twoHundredDayAverageChange": -0.22692502, "twoHundredDayAverageChangePercent": -0.1298997, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": 2.63158, "postMarketPrice": 1.56, "postMarketChange": 0.04, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.51 - 1.5801", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2028366, "fiftyTwoWeekLowChange": 0.52, "fiftyTwoWeekLowChangePercent": 0.52, "fiftyTwoWeekRange": "1.0 - 6.65", "fiftyTwoWeekHighChange": -5.13, "fiftyTwoWeekHighChangePercent": -0.7714286, "fiftyTwoWeekChangePercent": -74.55771, "epsTrailingTwelveMonths": -1.97, "epsForward": -1.64, "epsCurrentYear": -1.8225, "priceEpsCurrentYear": -0.8340192, "displayName": "Immuneering", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]